Duaklir Pressair

Active Ingredient(s): Aclidinium Bromide + Formoterol Fumarate
FDA Approved: * March 29, 2019
Pharm Company: * ASTRAZENECA PHARMS
Category: Lungs (Pulmonary)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Duaklir Pressair Overview

Aclidinium/formoterol (trade names Duaklir and Brimica) is a combination drug for inhalation, used in the management of chronic obstructive pulmonary disease (COPD). It consists of aclidinium bromide, a long-acting muscarinic antagonist, and formoterol, a long-acting β2 agonist.[1] References ^ "Duaklir Genuair". European Medicines Agency. 2014-12-05. Retrieved 2015-06-01..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\""...

Read more Duaklir Pressair Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Aclidinium/formoterol

Recent Duaklir Pressair Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Drugs with one or more similar ingredients: (10 results)

• ACLIDINIUM BROMIDE + FORMOTEROL FUMARATE
• ACLIDINIUM BROMIDE
• BEVESPI AEROSPHERE Glycopyrrolate + Formoterol Fumarate1 discussion
• BUDESONIDE/FORMOTEROL FUMARATE DIHYDRATE 1 discussion
• DULERA Mometasone Furoate + Formoterol Fumarate2 discussions
• FORADIL CERTIHALER Formoterol Fumarate
• GLYCOPYRROLATE + FORMOTEROL FUMARATE
• MOMETASONE FUROATE + FORMOTEROL FUMARATE
• SYMBICORT Budesonide/formoterol Fumarate Dihydrate39 discussions
• TUDORZA PRESSAIR Aclidinium Bromide1 discussion

Related Duaklir Pressair Topics: